Sanoma received a leading CDP rating of A- for its climate work for the third consecutive year
EET Sanoma received a leading CDP rating of A- for its climate work for the third consecutive year Sanoma was awarded with the leadership level score of A- in the global CDP Climate Change rating for ...
Sanoma Corp: Sanoma received a leading CDP rating of A- for its climate work for the third consecutive year
EET Sanoma received a leading CDP rating of A- for its climate work for the third consecutive year Sanoma was awarded with the leadership ...
ZAWYA2d
Tetra Pak awarded an 'A' score by the Carbon Disclosure Project for climate transparency
Tetra Pak, a global leader in food processing and packaging solutions, has once again demonstrated its commitment to ...
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
Aptar was recognized for its actions to cut emissions, mitigate climate risks and further the low-carbon economy, based on ...
Vietnam Investment Review on MSN6d
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it ...
Kensing Named To CDP's A List For Climate Leadership And Retains Ecovadis Gold Rating
Kensing's A- score for climate change reflects its robust efforts to minimize carbon emissions, source renewable electricity, ...
Morningstar6d
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year
According to CDP's scoring methodology, companies are evaluated on their awareness of environmental issues, management methods and advancements in environmental stewardship. Assessments are ...
Temenos continues to top ESG ratings from Dow Jones, S&P Global, Sustainalytics and CDP
Consistently strong ESG ratings reflect Temenos’ leadership in sustainability for the banking industryGRAND-LANCY, Switzerland, March 26, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader ...
Applied Clinical Trials Online2d
Results of Phase III HERCULES, GEMINI 1 and 2 Trials Lead to FDA Priority Review for Tolebrutinib for Non-Relapsing Secondary Progressive MS
FDA grants Priority Review status to Sanofi's tolebrutinib for the treatment of non-relapsing secondary progressive multiple ...